Skip to main content
. Author manuscript; available in PMC: 2012 Oct 19.
Published in final edited form as: Biochem Biophys Res Commun. 2012 Jul 20;425(2):177–181. doi: 10.1016/j.bbrc.2012.07.062

Figure 1.

Figure 1

p38 and Akt inhibitors attenuate the Cyclosporine A-augmented growth of cutaneous SCCs in xenograft murine model. (A) Profile of tumor growth (B) Histology of tumors excised from various treatment groups.